Picture Berlin Partner BIO 2024 International Convention San Diego 650x100px

Document › Details

Merck KGaA. (11/19/18). "Press Release: Merck and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer [Not intended for US, Canada and UK-based media]". Darmstadt.

	Organisation	Merck KGaA
	Group	Merck (DE) (Group)
	Organisation 2	Pfizer Inc. (NYSE: PFE)
	Group	Pfizer (Group)
	Product	avelumab (MSB0010718C)
	Product 2	clinical research
	Person	Boshoff, Chris (Pfizer 201610 Head of Immuno-Oncology, Early Developm + Translational Oncology)
	Person 2	Rossetti, Luciano (Flagship Pioneering 202101– CMO + Head RnD of Pioneering Medicines before Merck (DE) + Merck (US))

Original document
accessed by [iito] on 2018-11-20

Record changed: 2023-06-05

Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x200px

More documents for Merck (DE) (Group)

[1] Merck KGaA. (4/25/24). "Press Release: Merck Invests More Than € 300 Million in New Life Science Research Center in Germany". Darmstadt....
[2] C4 Therapeutics, Inc.. (3/4/24). "Press Release: C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Germany, Against Critical Oncogenic Proteins". Watertown, MA....
[3] Precirix N.V.. (2/29/24). "Press Release: Tom Plitz Commences Role as Chief Executive Officer of Precirix". Brussels....
[4] Merck KGaA. (1/4/24). "Press Release: Merck Expands Colorectal Cancer Portfolio Through Licensing Agreement with Inspirna [Not intended for UK-, US- or Canada-based media]". Darmstadt....
[5] Merck KGaA. (12/4/23). "Press Release: Merck Strengthens Oncology Portfolio through Commercialization Agreement With Abbisko for Phase III Asset, Pimicotinib [Not intended for UK-, US- or Canada-based media]". Darmstadt....
[6] Merck KGaA. (11/14/23). "Press Release: Merck Announces Plans for New U.S. Healthcare Headquarters in Boston’s Seaport District [Not intended for US-based media]". Darmstadt....
[7] Exscientia plc. (10/3/23). "Press Release: Exscientia Details Pipeline Prioritisation Strategy". Oxford....
[8] BenevolentAI. (9/20/23). "Press Release: BenevolentAI Signs Strategic Collaboration with Merck". London....
[9] Exscientia plc. (9/20/23). "Press Release: Exscientia Announces AI Drug Discovery Collaboration with Merck KGaA, Darmstadt, Germany". Oxford....
[10] Merck KGaA. (9/12/23). "Press Release: Merck Appoints Axel Löber as Head of Global Communications and Stakeholder Engagement". Darmstadt....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]